12Feb 2021
Apocrine ductal carcinoma in situ associated with testosterone therapy in a transgender individual

Apocrine ductal carcinoma in situ associated with testosterone therapy in a transgender individual

We report the first case of apocrine ductal carcinoma in situ (DCIS) in a female‐to‐male transgender individual on testosterone therapy (TT). The gender confirmation total mastectomy revealed 2 cm DCIS with apocrine cytology, high nuclear grade with associated calcification, and necrosis.

  • #gynaecology - ivf

Like

Save

Share